Arrowhead Pharmaceuticals Inc (ARWR)

Net profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-296,814	-205,275	-181,107	-150,207	-154,516	-176,063	-153,926	-111,804	-182,988	-140,848	-125,907	-109,594	-102,612	-84,553	-24,415	9,532	53,265	67,975	45,509	9,567
Revenue (ttm)	US$ in thousands	166,263	225,258	245,998	267,743	278,338	243,231	249,939	263,418	144,424	138,288	107,638	89,123	79,841	87,993	123,653	138,974	163,593	168,796	136,758	94,788
Net profit margin		-178.52%	-91.13%	-73.62%	-56.10%	-55.51%	-72.39%	-61.59%	-42.44%	-126.70%	-101.85%	-116.97%	-122.97%	-128.52%	-96.09%	-19.74%	6.86%	32.56%	40.27%	33.28%	10.09%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-296,814K ÷ $166,263K
= -178.52%

Arrowhead Pharmaceuticals Inc. has shown fluctuating net profit margins over the past eight quarters, with significant variability in profitability. The net profit margin has ranged from -163.32% in Q1 2024 to -42.44% in Q2 2022. This indicates that the company has been experiencing challenges in generating profits relative to its revenue during these periods. The negative net profit margins suggest that Arrowhead Pharmaceuticals Inc. has been incurring higher costs than its revenue, resulting in overall losses. It is important for the company to focus on improving cost management and operational efficiency to enhance profitability in the future.